PRESSUREwire Study
Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures
Sponsor: Abbott Medical Devices
Listed as NCT02935088, this observational or N/A phase trial focuses on Acute Coronary Syndrome and Coronary Artery Disease and remains completed. Sponsored by Abbott Medical Devices, it has been updated 19 times since 2016, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
19 versions recorded-
Feb 2026 — Present [monthly]
Completed
-
Dec 2025 — Feb 2026 [monthly]
Completed
-
Nov 2025 — Dec 2025 [monthly]
Completed
-
Sep 2025 — Nov 2025 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
▶ Show 14 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Jan 2021 — Dec 2022 [monthly]
Completed
-
Mar 2020 — Jan 2021 [monthly]
Completed
-
Jul 2019 — Mar 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2019 — Jul 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
-
Apr 2017 — Oct 2017 [monthly]
Recruiting NA
-
Feb 2017 — Apr 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Almada, Portugal , Amsterdam, Netherlands , Aswān, Egypt , Athens, Greece , Bilbao, Spain , Bologna, Italy , Breda, Netherlands , Burgos, Spain , Cairo, Egypt and 58 more locations